Stockreport

While shareholders of Y-mAbs Therapeutics (NASDAQ:YMAB) are in the black over 1 year, those who bought a week ago aren't so fortunate [Yahoo! Finance]

Y-mAbs Therapeutics, Inc.  (YMAB) 
Last y-mabs therapeutics, inc. earnings: 11/13 04:01 pm Check Earnings Report
PDF Y-mAbs Therapeutics, Inc. NASDAQ:YMAB ) share price has soared 142% in the last 1 year. Most would be very happy with that, especially in just one year! But it's down 9 [Read more]